B-arrestins regulate stem cell-like phenotype and response to chemotherapy in bladder cancer

Georgios Kallifatidis, Diandra K. Smith, Daley S. Morera, Jie Gao, Martin J. Hennig, James J. Hoy, Richard F. Pearce, Isha R. Dabke, Jiemin Li, Axel S. Merseburger, Markus A. Kuczyk, Vinata B Lokeshwar, Balakrishna L Lokeshwar

Research output: Contribution to journalArticle

Abstract

b-Arrestins are classic attenuators of G-protein–coupled receptor signaling. However, they have multiple roles in cellular physiology, including carcinogenesis. This work shows for the first time that b-arrestins have prognostic significance for predicting metastasis and response to chemotherapy in bladder cancer. b-Arrestin-1 (ARRB1) and b-arrestin-2 (ARRB2) mRNA levels were measured by quantitative RT-PCR in two clinical specimen cohorts (n ¼ 63 and 43). The role of ARRBs in regulating a stem cell-like phenotype and response to chemotherapy treatments was investigated. The consequence of forced expression of ARRBs on tumor growth and response to Gemcitabine in vivo were investigated using bladder tumor xenografts in nude mice. ARRB1 levels were significantly elevated and ARRB2 levels downregulated in cancer tissues compared with normal tissues. In multivariate analysis only ARRB2 was an independent predictor of metastasis, disease-specific-mortality, and failure to Gemcitabine þ Cisplatin (GþC) chemotherapy; 80% sensitivity and specificity to predict clinical outcome. ARRBs were found to regulate stem cell characteristics in bladder cancer cells. Depletion of ARRB2 resulted in increased cancer stem cell markers but ARRB2 overexpression reduced expression of stem cell markers (CD44, ALDH2, and BMI-1), and increased sensitivity toward Gemcitabine. Overexpression of ARRB2 resulted in reduced tumor growth and increased response to Gemcitabine in tumor xenografts. CRISPR-Cas9–mediated gene-knockout of ARRB1 resulted in the reversal of this aggressive phenotype. ARRBs regulate cancer stem cell-like properties in bladder cancer and are potential prognostic indicators for tumor progression and chemotherapy response.

Original languageEnglish (US)
Pages (from-to)801-811
Number of pages11
JournalMolecular cancer therapeutics
Volume18
Issue number4
DOIs
StatePublished - Apr 1 2019

Fingerprint

Arrestins
gemcitabine
Urinary Bladder Neoplasms
Stem Cells
Phenotype
Drug Therapy
Neoplastic Stem Cells
Neoplasms
Heterografts
Clustered Regularly Interspaced Short Palindromic Repeats
Neoplasm Metastasis
Arrestin
Gene Knockout Techniques
Growth
Nude Mice
Cisplatin
beta-Arrestin 1
Carcinogenesis
Down-Regulation
Multivariate Analysis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

B-arrestins regulate stem cell-like phenotype and response to chemotherapy in bladder cancer. / Kallifatidis, Georgios; Smith, Diandra K.; Morera, Daley S.; Gao, Jie; Hennig, Martin J.; Hoy, James J.; Pearce, Richard F.; Dabke, Isha R.; Li, Jiemin; Merseburger, Axel S.; Kuczyk, Markus A.; Lokeshwar, Vinata B; Lokeshwar, Balakrishna L.

In: Molecular cancer therapeutics, Vol. 18, No. 4, 01.04.2019, p. 801-811.

Research output: Contribution to journalArticle

Kallifatidis, G, Smith, DK, Morera, DS, Gao, J, Hennig, MJ, Hoy, JJ, Pearce, RF, Dabke, IR, Li, J, Merseburger, AS, Kuczyk, MA, Lokeshwar, VB & Lokeshwar, BL 2019, 'B-arrestins regulate stem cell-like phenotype and response to chemotherapy in bladder cancer', Molecular cancer therapeutics, vol. 18, no. 4, pp. 801-811. https://doi.org/10.1158/1535-7163.MCT-18-1167
Kallifatidis, Georgios ; Smith, Diandra K. ; Morera, Daley S. ; Gao, Jie ; Hennig, Martin J. ; Hoy, James J. ; Pearce, Richard F. ; Dabke, Isha R. ; Li, Jiemin ; Merseburger, Axel S. ; Kuczyk, Markus A. ; Lokeshwar, Vinata B ; Lokeshwar, Balakrishna L. / B-arrestins regulate stem cell-like phenotype and response to chemotherapy in bladder cancer. In: Molecular cancer therapeutics. 2019 ; Vol. 18, No. 4. pp. 801-811.
@article{5e0efee9523a45149231de38f24a54fe,
title = "B-arrestins regulate stem cell-like phenotype and response to chemotherapy in bladder cancer",
abstract = "b-Arrestins are classic attenuators of G-protein–coupled receptor signaling. However, they have multiple roles in cellular physiology, including carcinogenesis. This work shows for the first time that b-arrestins have prognostic significance for predicting metastasis and response to chemotherapy in bladder cancer. b-Arrestin-1 (ARRB1) and b-arrestin-2 (ARRB2) mRNA levels were measured by quantitative RT-PCR in two clinical specimen cohorts (n ¼ 63 and 43). The role of ARRBs in regulating a stem cell-like phenotype and response to chemotherapy treatments was investigated. The consequence of forced expression of ARRBs on tumor growth and response to Gemcitabine in vivo were investigated using bladder tumor xenografts in nude mice. ARRB1 levels were significantly elevated and ARRB2 levels downregulated in cancer tissues compared with normal tissues. In multivariate analysis only ARRB2 was an independent predictor of metastasis, disease-specific-mortality, and failure to Gemcitabine {\th} Cisplatin (G{\th}C) chemotherapy; 80{\%} sensitivity and specificity to predict clinical outcome. ARRBs were found to regulate stem cell characteristics in bladder cancer cells. Depletion of ARRB2 resulted in increased cancer stem cell markers but ARRB2 overexpression reduced expression of stem cell markers (CD44, ALDH2, and BMI-1), and increased sensitivity toward Gemcitabine. Overexpression of ARRB2 resulted in reduced tumor growth and increased response to Gemcitabine in tumor xenografts. CRISPR-Cas9–mediated gene-knockout of ARRB1 resulted in the reversal of this aggressive phenotype. ARRBs regulate cancer stem cell-like properties in bladder cancer and are potential prognostic indicators for tumor progression and chemotherapy response.",
author = "Georgios Kallifatidis and Smith, {Diandra K.} and Morera, {Daley S.} and Jie Gao and Hennig, {Martin J.} and Hoy, {James J.} and Pearce, {Richard F.} and Dabke, {Isha R.} and Jiemin Li and Merseburger, {Axel S.} and Kuczyk, {Markus A.} and Lokeshwar, {Vinata B} and Lokeshwar, {Balakrishna L}",
year = "2019",
month = "4",
day = "1",
doi = "10.1158/1535-7163.MCT-18-1167",
language = "English (US)",
volume = "18",
pages = "801--811",
journal = "Molecular Cancer Therapeutics",
issn = "1535-7163",
publisher = "American Association for Cancer Research Inc.",
number = "4",

}

TY - JOUR

T1 - B-arrestins regulate stem cell-like phenotype and response to chemotherapy in bladder cancer

AU - Kallifatidis, Georgios

AU - Smith, Diandra K.

AU - Morera, Daley S.

AU - Gao, Jie

AU - Hennig, Martin J.

AU - Hoy, James J.

AU - Pearce, Richard F.

AU - Dabke, Isha R.

AU - Li, Jiemin

AU - Merseburger, Axel S.

AU - Kuczyk, Markus A.

AU - Lokeshwar, Vinata B

AU - Lokeshwar, Balakrishna L

PY - 2019/4/1

Y1 - 2019/4/1

N2 - b-Arrestins are classic attenuators of G-protein–coupled receptor signaling. However, they have multiple roles in cellular physiology, including carcinogenesis. This work shows for the first time that b-arrestins have prognostic significance for predicting metastasis and response to chemotherapy in bladder cancer. b-Arrestin-1 (ARRB1) and b-arrestin-2 (ARRB2) mRNA levels were measured by quantitative RT-PCR in two clinical specimen cohorts (n ¼ 63 and 43). The role of ARRBs in regulating a stem cell-like phenotype and response to chemotherapy treatments was investigated. The consequence of forced expression of ARRBs on tumor growth and response to Gemcitabine in vivo were investigated using bladder tumor xenografts in nude mice. ARRB1 levels were significantly elevated and ARRB2 levels downregulated in cancer tissues compared with normal tissues. In multivariate analysis only ARRB2 was an independent predictor of metastasis, disease-specific-mortality, and failure to Gemcitabine þ Cisplatin (GþC) chemotherapy; 80% sensitivity and specificity to predict clinical outcome. ARRBs were found to regulate stem cell characteristics in bladder cancer cells. Depletion of ARRB2 resulted in increased cancer stem cell markers but ARRB2 overexpression reduced expression of stem cell markers (CD44, ALDH2, and BMI-1), and increased sensitivity toward Gemcitabine. Overexpression of ARRB2 resulted in reduced tumor growth and increased response to Gemcitabine in tumor xenografts. CRISPR-Cas9–mediated gene-knockout of ARRB1 resulted in the reversal of this aggressive phenotype. ARRBs regulate cancer stem cell-like properties in bladder cancer and are potential prognostic indicators for tumor progression and chemotherapy response.

AB - b-Arrestins are classic attenuators of G-protein–coupled receptor signaling. However, they have multiple roles in cellular physiology, including carcinogenesis. This work shows for the first time that b-arrestins have prognostic significance for predicting metastasis and response to chemotherapy in bladder cancer. b-Arrestin-1 (ARRB1) and b-arrestin-2 (ARRB2) mRNA levels were measured by quantitative RT-PCR in two clinical specimen cohorts (n ¼ 63 and 43). The role of ARRBs in regulating a stem cell-like phenotype and response to chemotherapy treatments was investigated. The consequence of forced expression of ARRBs on tumor growth and response to Gemcitabine in vivo were investigated using bladder tumor xenografts in nude mice. ARRB1 levels were significantly elevated and ARRB2 levels downregulated in cancer tissues compared with normal tissues. In multivariate analysis only ARRB2 was an independent predictor of metastasis, disease-specific-mortality, and failure to Gemcitabine þ Cisplatin (GþC) chemotherapy; 80% sensitivity and specificity to predict clinical outcome. ARRBs were found to regulate stem cell characteristics in bladder cancer cells. Depletion of ARRB2 resulted in increased cancer stem cell markers but ARRB2 overexpression reduced expression of stem cell markers (CD44, ALDH2, and BMI-1), and increased sensitivity toward Gemcitabine. Overexpression of ARRB2 resulted in reduced tumor growth and increased response to Gemcitabine in tumor xenografts. CRISPR-Cas9–mediated gene-knockout of ARRB1 resulted in the reversal of this aggressive phenotype. ARRBs regulate cancer stem cell-like properties in bladder cancer and are potential prognostic indicators for tumor progression and chemotherapy response.

UR - http://www.scopus.com/inward/record.url?scp=85064197591&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064197591&partnerID=8YFLogxK

U2 - 10.1158/1535-7163.MCT-18-1167

DO - 10.1158/1535-7163.MCT-18-1167

M3 - Article

VL - 18

SP - 801

EP - 811

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

SN - 1535-7163

IS - 4

ER -